en · de · es · fr · pt
sr9009-notes.peptides6579.com › Topic › Analytical Detection And Laboratory Handling — What the Evidence Shows

Analytical Detection And Laboratory Handling — What the Evidence Shows

By Editorial Desk · published 2026-05-19 · last reviewed 2026-06-07 · Topic

This is a working overview of LC-MS, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2026-06-07. Anything still debated is marked as such rather than presented as settled.

Analytical Detection and Laboratory Handling

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.

Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.

Identity, Handling, and Regulation

Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.

In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.

Sr9009 at a glance

PropertyValueNotes
AppearanceOff-white to pale yellow solidVisual description varies with purity and source
SolubilitySoluble in DMSO and ethanol; poorly soluble in waterOrganic stock solutions are common in research
Typical storage-20 °C, desiccated, protected from lightAvoid repeated freeze-thaw cycles
Typical analytical methodLC-MS or HPLC-UVReference standards are needed for quantification
Molar massApproximately 437.9 g/molCalculated from the reported free-base formula

Handling, Analysis, and Regulation

Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.

Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.

Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.

Related pages on this site

Background and Research Status

REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.

Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.

Reference notes

== Chemical properties == It reacts with cesium fluorosulfonate and silver fluorosulfonate to produce the divalent silver compound CsAg(SO3F)3. Iodine(I) fluorosulfonate can be obtained from iodine and peroxydisulfuryl difluoride:

In 1985, daily television images of confrontations between gun-wielding policemen and rock-throwing youths fuelled the debate in international circles over whether or not to impose sanctions on South Africa.

== Secretion and Regulation == Release of little gastrin I is triggered by the presence of proteins and amino acids in the stomach, gastric distension as well as elevated stomach pH. The release is also promoted by vagal nerve stimulation. Secretion is inhibited by Somatostatin and by acidic gastric pH. This forms a negative feedback loop. Its half-life in circulation is short, around 3-7 minutes, after which it is mainly broken down by the kidneys .

The process of population relaxation refers to nuclear spins that return to thermodynamic equilibrium in the magnet. This process is also called T1, "spin–lattice" or "longitudinal magnetic" relaxation, where T1 refers to the mean time for an individual nucleus to return to its thermal equilibrium state of the spins. After the nuclear spin population has relaxed, it can be probed again, since it is in the initial, equilibrium (mixed) state. The precessing nuclei can also fall out of alignment with each other and gradually stop producing a signal. This is called T2, "spin–spin" or transverse relaxation. Because of the difference in the actual relaxation mechanisms involved (for example, intermolecular versus intramolecular magnetic dipole-dipole interactions), T1 is usually (except in rare cases) longer than T2 (that is, slower spin–lattice relaxation, for example because of smaller dipole-dipole interaction effects). In practice, the value of T2*, which is the actually observed decay time of the observed NMR signal, or free induction decay (to ⁠1/e⁠ of the initial amplitude immediately after the resonant RF pulse), also depends on the static magnetic field inhomogeneity, which may be quite significant. (There is also a smaller but significant contribution to the observed FID shortening from the RF inhomogeneity of the resonant pulse). In the corresponding FT–NMR spectrum – meaning the Fourier transform of the free induction decay – the width of the NMR signal in frequency units is inversely related to the T2* time.

The Federal Medical Center, Rochester (FMC Rochester) is a United States federal prison in Minnesota for male inmates requiring specialized or long-term medical or mental health care. It is designated as an administrative facility, which means it holds inmates of all security classifications. It is operated by the Federal Bureau of Prisons, a division of the United States Department of Justice. FMC Rochester is located in southeastern Minnesota, 2 miles (3.2 km) east of downtown Rochester.

Sources: en.wikipedia.org

Reference notes

==== Checks and balances ==== In March 2025 Larson showed visible frustration at Elon Musk's failure to appear before the House Ways and Means Committee and answer DOGE data transparency questions. On April 6, 2026, Larson filed articles of impeachment against President Donald Trump.

==== 3.E. Light absorption-driven transporters ==== Bacteriorhodopsin-like proteins including rhodopsin (see also opsin) Bacterial photosynthetic reaction centres and photosystems I and II Light harvesting complexes from bacteria and chloroplasts

== See also == Family tree of German monarchs – he was related to every other ruler of Germany List of coupled cousins Austro-Hungarian entry into World War I Franc Jozeph Island, island in Albania named in honor of the Emperor. Order of St. George (Habsburg-Lorraine) Franz Josef Glacier was named after Emperor Franz Joseph I by the German geologist Julius von Haast in 1865.

=== Regulation of expression === EPCIP is expressed during blastocyst, fetus, and adult states of human development. It is overexpressed during some tumor states, including pancreatic, gastrointestinal, germ cell, and glioma tumors.

== Side effects == 5-ARIs are generally well tolerated in both men and women and produce few side effects. However, they have been found to have some risks in studies with men, including slightly increased risks of decreased libido, erectile dysfunction, ejaculatory dysfunction, infertility, breast tenderness, gynecomastia, depression, anxiety, self-harm, and dementia. In addition, although 5-ARIs decrease the overall risk of developing prostate cancer, they have been found to increase the risk of developing certain rare but high-grade forms of prostate cancer. As a result, the FDA has notified healthcare professionals that the Warnings and Precautions section of the labels for the 5-ARI class of drugs has been revised to include new safety information about the increased risk of being diagnosed with these rare but more serious forms of prostate cancer. Finasteride has also been associated with intraoperative floppy iris syndrome and cataract formation. Depressive symptoms and suicidality have been reported.

Sources: en.wikipedia.org

Frequently asked questions

How is SR9009 detected?

It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.

What is known about its stability?

The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.

Why does solubility matter?

Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.

How is SR9009 usually analyzed?

Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.

Network